GPT Healthcare Limited announced receipt of a SEBI-approved certificate under Regulation 74(5) confirming no dematerialization/rematerialization requests were received for the quarter ended June 30, 2026, ensuring compliance with depositary regulations and shareholding continuity.
Sign up to read summaryGPT Healthcare Limited announced its 37th AGM scheduled for August 6, 2026, via video conferencing, with final dividend of โน1.50 per share (15%) payable by September 4, 2026, on record date July 30, 2026. Shareholders must complete e-voting between August 3-5, 2026, and ensure updated KYC and dematerialized shares. The notice includes re-appointments of independent directors, approval of related party remuneration for Dr. Mridul Tantia (โน5 lakh/month) and Dr. Niharika Tantia, and ratification of auditor fees. Compliance requirements include mandatory electronic dividend payments, updated shareholder details via Form ISR-4, and submission of tax documents by July 30, 2026, to claim treaty benefits.
Sign up to read summaryGPT Healthcare Limited announced that its trading window will close on July 1, 2026, and remain closed for 48 hours after the release of un-audited Q1 results ending June 30, 2026, as required by SEBI insider trading regulations.
Sign up to read summaryGPT Healthcare Limited announced on June 8, 2026 that it has dispatched communications to shareholders with unpaid or unclaimed dividends as part of the second 100 days investor awareness campaign called Saksham Niveshak. The initiative aims to help shareholders claim pending dividends, complete KYC updates, and prevent shares or dividends from being transferred to the Investor Education and Protection Fund. The company emphasized the importance of timely action to avoid regulatory complications and highlighted available resources on its website and through its registrar.
Sign up to read summary